不同的细胞机制是反CTLA-4和反PD-1检查点的基础
Spencer C Wei1, Jacob H Levine2, Alexandria P Cogdill3
1Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Cell
|August 15, 2017
概括
免疫检查点阻塞,包括抗CTLA-4和抗PD-1疗法,针对瘤中的特定T细胞子集. 这些疗法激活不同的免疫细胞机制, 通过不同的途径导致瘤排斥.
科学领域:
- 免疫学
- 癌症研究
- T细胞生物学
背景情况:
- 免疫检查点阻塞 (ICB) 在一些癌症患者中提供了持久的反应.
- 了解抗CTLA-4和抗PD-1在瘤排斥中的机制是有限的.
研究的目的:
- 综合描述ICB对瘤免疫透物的影响.
- 阐明抗CTLA-4和抗PD-1疗法的独特细胞机制.
主要方法:
- 使用质量细胞测量分析瘤免疫透物.
- 研究了人类黑色素瘤和小鼠瘤模型.
主要成果:
- 针对瘤透T细胞的特定子集.
- 抗PD-1扩大了CD8T细胞的消耗样子.
- 抗CTLA-4可扩展ICOS+ Th1型CD4效应细胞和特定的耗尽型CD8T细胞.
结论:
- 抗CTLA-4和抗PD-1对瘤排斥有不同的细胞机制.
- 这些发现提供了关于ICB反应异质性的见解.
相关概念视频
T Cell Activation and Clonal Selection
16.5K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
16.5K
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cytotoxic T Cells-mediated Immune Response
7.6K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.6K
Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
T Cell Types and Functions
2.8K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.8K
The Intrinsic Apoptotic Pathway
8.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.8K


